July 25, 2011

A phrase like “silent killer” sounds creepy enough on its own, but it’s an often-used one for a virus that, according to the Centers for Disease Control and Prevention, infects 1.3% to 1.9% of people in the United States.


July 18, 2011

Walgreens is recognizing medication adherence rates as high as 96% through its hepatitis C therapy management programs across its specialty pharmacy, the pharmacy operator announced Monday.

July 6, 2011

Pharmacy benefit manager Medco Health Solutions’ specialty pharmacy division, Accredo Health Group, has managed to drive down costs for treating hepatitis C by an average of $13,000 per patient, the company said Tuesday.

June 16, 2011

Specialty pharmacy provider Axium Healthcare Pharmacy has introduced two recently approved hepatitis C drugs to its HepVisions therapy management program, the company said Thursday.

June 3, 2011

CVS Caremark is enhancing its hepatitis C patient support program following the recent Food and Drug Administration approval of two new add-on therapies for hepatitis C, the company announced on Friday.

May 23, 2011

The Food and Drug Administration has approved a treatment for hepatitis C made by Vertex Pharmaceuticals, the agency said Monday.

May 23, 2011

The $290 billion that poor medication adherence costs the U.S. economy every year cuts across every imaginable disease state, but one in which it can be particularly problematic is mental health.


May 16, 2011

The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.

May 9, 2011

Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.

April 12, 2011

Medication adherence among hepatitis C patients may improve when patients take antidepressants, according to a new analysis by pharmacy benefit manager Medco Health Solutions presented Monday at the International Conference on Viral Hepatitis.

January 20, 2011

The Food and Drug Administration and Health Canada have granted priority review to a drug for treating hepatitis C.

November 4, 2010

An investigative treatment for hepatitis C got strong results in patients who had failed previous...

October 31, 2010

Drug makers Valeant Pharmaceuticals International and Kadmon Pharmaceuticals will collaborate to develop antiviral drugs for...

October 7, 2010

Swiss drug maker Roche has bought the rights to an investigative treatment for hepatitis C,...

September 27, 2010

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 21, 2010

Merck is expanding its patient assistance program, the drug maker said Wednesday....

September 7, 2010

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

August 11, 2010

An investigational drug made by Pharmasset for treating hepatitis C will get expedited review from...

August 8, 2010

An investigational drug in late-stage clinical trials increased the cure rate in patients with hepatitis...

June 24, 2010

The Food and Drug Administration has approved a new rapid blood test for detecting hepatitis...

June 9, 2010

Idenix Pharmaceuticals has started a proof-of-concept study of an investigational drug for hepatitis C currently...

May 25, 2010

A majority of people taking an investigational treatment for hepatitis C were cured after taking...

March 18, 2010

“Systemic underfunding” at the Centers for Disease Control and Prevention’s Division of Viral Hepatitis puts...

March 1, 2010

The market for hepatitis C drugs could get a boost if a clinical trial program...